Bg pattern

CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

ProspectusInformationfor the User

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

C

chlorhexidine digluconate

Read the entire prospectus carefully before starting to use this medication, as it contains important information for you

Follow the administration instructions for the medication contained in this prospectus or as indicated by your doctor or nurse exactly.

  • Keep this prospectus, as you may need to read it again.
  • If you need advice or more information, consult your doctor or nurse.
  • If you experience adverse effects, consult your doctor or nurse, even if they are adverse effects that do not appear in this prospectus. See section 4.

Contents of the Prospectus

  1. What is Clorhexlan and what is it used for.
  2. What you need to know before starting to use Clorhexlan
  3. How to use Clorhexlan
  4. Possible adverse effects
  5. Storage of Clorhexlan
  6. Content of the packaging and additional information
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

1. What is Clorhexlan and what is it used for

Clorhexlan 20 mg/ml is a solution for cutaneous use whose active ingredient is chlorhexidine digluconate.

It is used in adults and children as a skin antiseptic, for the prevention of infections, before performing invasive medical procedures, such as injections, insertion of intravascular catheters, minor and major surgery.

2. What you need to know before starting to use Clorhexlan

Do not use Clorhexlan

If you are allergic (hypersensitive) to chlorhexidine digluconate or to any of the other components of this medication (included in section 6).

Warnings and precautions

Consult your doctor or nurse before starting to use this medication.

Clorhexlan is for external use on the skin only. Do not ingest.

Clorhexlan should not be used:

  • Near sensitive areas (mucous membranes), as it may cause irritation. In case of contact with the mucous membranes of the body's entry points, the affected area should be washed immediately with plenty of water.
  • Clorhexlan should not come into contact with the eyes due to the risk of visual damage. If it comes into contact with the eyes, wash immediately and abundantly with water. In case of irritation, redness, or pain in the eyes, or visual disturbances, consult a doctor immediately.

Severe cases of persistent corneal injury (injury to the surface of the eye) that could require a corneal transplant have been reported when similar products have accidentally come into contact with the eyes during surgical interventions, in patients under general anesthesia (deep sleep induced without pain).

  • On open wounds.
  • On the inner part of the ear (middle ear).
  • In direct contact with neural tissue (e.g., brain and spinal cord).

Avoid prolonged contact with the skin. When applying an occlusive dressing to areas previously exposed to Clorhexlan, special care should be taken to ensure that there is no excess product before placing the dressing.

Do not use excessive amounts and avoid accumulating the solution in skin folds, under the patient, or soaking bedding or other materials in direct contact with the patient.

Soaked materials, such as surgical fields or gowns, should be removed before use. Do not let the solution stagnate.

Clorhexlan may, in rare cases, cause severe allergic reactions, leading to a decrease in blood pressure and even loss of consciousness. The first symptoms of a severe allergic reaction may be skin rash or asthma. If you notice these symptoms, stop using this medication and contact your doctor as soon as possible (see section 4: "Possible adverse effects").

Children

Use with caution in neonates, especially in premature babies. Clorhexlan as a skin antiseptic before invasive procedures may cause chemical burns on the skin of neonates.

Use with caution in neonates, especially in those born before 32 weeks of gestation and in the first two weeks of life.

Other medications and Clorhexlan

The action of chlorhexidine is reduced by alkaline pH, anionic detergents, and tannins:

  • In general, considering possible interference (antagonism, inactivation, etc.), the simultaneous or successive use of antiseptics should be avoided, except with other cationic compounds.
  • It should not be used in combination or after the application of anionic soaps, iodine, heavy metal salts, and acids.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medication.

Driving and using machines

Clorhexlan does not alter the ability to drive or operate machines.

3. How to use Clorhexlan

Your doctor or nurse will select the necessary amount of solution based on the medical procedure, the area to be treated, and the area to be covered. In case of doubt, ask your doctor or pharmacist.

Use undiluted. Clean and dry the skin before applying the medication. Apply directly to the affected area or to a gauze. Let it act for the time indicated based on the medical procedure.

Clorhexlan is only used on the skin.

If you use more Clorhexlan than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

4. Possible adverse effects

Like all medications, this medication may cause adverse effects, although not all people experience them.

Stop treatment with this medication if you experience any of the following symptoms: swelling of the face, lips, tongue, or throat; red eczema on the skin that causes itching; difficulty breathing; feeling of dizziness or fainting, metallic taste; collapse. You may be experiencing an allergic reaction if these symptoms appear.

Stop using this medication and consult your doctor or nurse if you experience eczema, blisters, inflammation, or experience pain or itching in the area of the skin where the product has been applied.

Other possible adverse effects are:

Very rare (less than 1 in 10,000 people):cutaneous hypersensitivity reactions (including erythema, rash, itching, and blisters at the administration site), burning sensation on the skin, pain, and inflammation. Stop using this medication and seek immediate medical attention if you experience any of the adverse reactions described. You may be having an allergic reaction.

Adverse effects of unknown frequency(cannot be estimated from the available data): dermatitis, eczema, urticaria, skin irritation, blisters, chemical burns in neonates, hypersensitivity reactions, and anaphylactic shock during anesthesia. Corneal injury (injury to the surface of the eye) and permanent eye injury, including permanent visual impairment (after accidental ocular exposure during surgical interventions in the head, face, and neck) in patients under general anesthesia (deep sleep induced without pain).

Reporting adverse effects:

If you experience any type of adverse effect, consult your doctor or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Clorhexlan

No special storage conditions are required.

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date that appears on the label after CAD. The expiration date is the last day of the month indicated.

Discard the packaging after 3 months from the first opening.

Medications should not be thrown away through the sewers or in the trash. In case of doubt, ask your pharmacist how to dispose of the packaging and medications that are no longer needed. This way, you will help protect the environment.

6. Content of the packaging and additional information

Composition of Clorhexlan

  • The active ingredient is chlorhexidine digluconate. Each ml contains 20 mg of chlorhexidine digluconate. Each ml corresponds to 5 pulses of 200 microliters, each containing 4 mg of chlorhexidine digluconate.
  • The other component (excipient) is purified water.

Appearance of Clorhexlan and content of the packaging

Colorless or slightly yellowish transparent solution presented in high-density polyethylene bottles with a spray pump.

It is presented in:

  • Unitary packages of 25 ml, 100 ml, and 125 ml.
  • Clinical packages of 20 bottles of 100 ml, 125 ml, and 250 ml.

Only some packaging sizes may be marketed.

Marketing authorization holder and manufacturer

LAINCO, S.A.

Avda. Bizet, 8-12 - 08191 RUBÍ - Barcelona (Spain)

Date of the last revision of this prospectus:August 2024

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION

Discuss questions about CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION?
CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION?
The active ingredient in CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION is chlorhexidine. This information helps identify medicines with the same composition but different brand names.
Who manufactures CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION?
CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION is manufactured by Lainco S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CHLORHEXLAN 20 mg/ml CUTANEOUS SPRAY SOLUTION?
Other medicines with the same active substance (chlorhexidine) include AQUASEPTIC PHARMA 20 mg/ml CUTANEOUS SOLUTION, AQUASEPTIC PHARMA ORANGE 20 mg/mL CUTANEOUS SOLUTION, CLORXIL 10 mg/ml CUTANEOUS SPRAY SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media